Loss of vision in glaucoma is presumed to be due to compression of the optic nerve (ON) head by increased intraocular pressure (IOP), followed by ON degeneration and retrograde death of retinal ganglion cells (RGCs). A better understanding of the mechanisms underlying the RGC and ON degeneration is a prerequisite for developing novel neuroprotective treatments which is currently not available in clinics. Recently endoplasmic reticulum (ER) stress has been shown to play a critical role in neuronal degeneration. Striking RGC-protection has been accomplished by manipulating two key downstream molecules of ER stress, deleting CCAAT/enhancer binding protein homologous protein (CHOP) or activating X-box binding protein 1 (XBP-1). Of special interest, blocking the negative effects of ER stress also inhibited RGC death in a mouse glaucoma model. Thus targeting ER stress may have considerable therapeutic neuroprotective potential in glaucoma. This application will determine whether manipulating ER stress signaling molecules also rescue injured RGC axons in addition to RGC soma protection, through morphology and functional studies. Furthermore, efforts will be made to develop adeno-associated virus (AAV)-mediated gene therapies targeting ER stress to prevent neurodegeneration in mouse glaucoma models. New insights into the critical molecules that regulate RGC soma and axon survival can be translated into novel therapeutic approaches to prevent vision loss in patients with glaucoma.

Public Health Relevance

The proposed experiments will enhance our understanding of the pathogenesis of axon and neuron degeneration in glaucoma and demonstrate the therapeutic potential of targeting ER stress in the highly relevant experimental models for glaucoma. The experiments therefore have the potential to develop novel treatments for this neurodegenerative disease.

National Institute of Health (NIH)
National Eye Institute (NEI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (DPVS)
Program Officer
Chin, Hemin R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Temple University
Schools of Medicine
United States
Zip Code
Zhang, Jie; Yang, Dakai; Huang, Haoliang et al. (2018) Coordination of Necessary and Permissive Signals by PTEN Inhibition for CNS Axon Regeneration. Front Neurosci 12:558
Huang, Haoliang; Miao, Linqing; Liang, Feisi et al. (2017) Neuroprotection by eIF2?-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss. Cell Death Dis 8:e2936
Prosseda, Philipp P; Luo, Na; Wang, Biao et al. (2017) Loss of OCRL increases ciliary PI(4,5)P2 in Lowe oculocerebrorenal syndrome. J Cell Sci 130:3447-3454
Wang, Qizhao; Wu, Zhongren; Zhang, Junping et al. (2017) A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors. Mol Ther Methods Clin Dev 7:146-156
Hu, Yang (2016) Axon injury induced endoplasmic reticulum stress and neurodegeneration. Neural Regen Res 11:1557-1559
Miao, Linqing; Yang, Liu; Huang, Haoliang et al. (2016) mTORC1 is necessary but mTORC2 and GSK3? are inhibitory for AKT3-induced axon regeneration in the central nervous system. Elife 5:e14908
Yang, Liu; Li, Shaohua; Miao, Linqing et al. (2016) Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules. J Neurosci 36:5891-903
Hu, Yang (2015) The necessary role of mTORC1 in central nervous system axon regeneration. Neural Regen Res 10:186-8
Yang, Liu; Miao, Linqing; Liang, Feisi et al. (2014) The mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration. Nat Commun 5:5416
Li, Shaohua; Yang, Liu; Selzer, Michael E et al. (2013) Neuronal endoplasmic reticulum stress in axon injury and neurodegeneration. Ann Neurol 74:768-77